Pharmaceutical Raw Materials and Excipients No Further a Mystery
“The current condition has uncovered some structural weaknesses while in the EU’s medicines supply chain and also a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She advised that provide chain issues be addressed in an EU pharmaceutical strategy predicted to become launched by the top of the